| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenue | $10.4M-25.4% | $14.0M-49.2% | $27.5M+29.1% | $21.3M+362.3% | $4.6M |
| Cost of goods sold | $130.8M+3.5% | $126.4M-5.4% | $133.6M+120.9% | $60.5M+110.7% | $28.7M |
| Research and development | $154.1M-12.0% | $175.1M+13.3% | $154.5M+27.5% | $121.2M+108.5% | $58.1M |
| Selling, general, and administrative | $77.7M-4.0% | $80.9M+14.8% | $70.5M+46.1% | $48.2M+32.6% | $36.4M |
| Restructuring costs | $9.1M+109.3% | $4.3M | $0 | $0 | — |
| Total operating expenses | $371.6M-3.9% | $386.8M+7.9% | $358.6M+56.0% | $229.9M+86.6% | $123.2M |
| Loss from operations | -$154.2M+9.3% | -$170.1M-25.6% | -$135.4M-13.7% | -$119.1M-59.3% | -$74.8M |
| Interest income | $7.3M+58.9% | $4.6M-41.2% | $7.8M+203.9% | $2.6M+5138.8% | $49K |
| Interest expense | -$17.6M-90.6% | -$9.3M-7.0% | -$8.7M-411.2% | -$1.7M-36.6% | -$1.2M |
| Gain from change in fair value of warrants | $0 | $0-100.0% | $7.1M-87.2% | $55.1M+311.3% | -$26.1M |
| Gain (loss) from change in fair value of contingent considerations and acquisition-related holdbacks | $7.0M-76.0% | $29.0M+1072.9% | -$3.0M-131.5% | $9.5M+11935.0% | -$80K |
| Gain from extinguishment of debt | $2.6M | $0 | $0 | — | $304K |
| Other income (expense) | $1.2M+411.8% | -$400K+66.0% | -$1.2M-998.1% | -$107K-354.8% | $42K |
| Total other income, net | $490K-98.0% | $24.0M+1065.3% | $2.1M-96.9% | $65.3M+247.9% | -$44.1M |
| Net loss before income taxes | -$153.7M-5.2% | -$146.1M-9.6% | -$133.4M-147.8% | -$53.8M+54.7% | -$118.9M |
| Income tax benefit | $3.0M+56.8% | $1.9M-57.6% | $4.5M+338.1% | $1.0M+216.5% | $327K |
| Net loss | -$150.7M-4.5% | -$144.2M-11.9% | -$128.8M-144.1% | -$52.8M+55.5% | -$118.6M |
| Less: Net loss attributable to noncontrolling interest | -$7.6M+34.0% | -$11.6M-3.4% | -$11.2M-19.4% | -$9.4M+69.3% | -$30.6M |
| Net loss attributable to indie Semiconductor, Inc. | -$143.1M-7.9% | -$132.6M-12.7% | -$117.6M-171.0% | -$43.4M+50.7% | -$88.0M |
| Net loss attributable to common shares —basic | -$143.1M-7.9% | -$132.6M-12.7% | -$117.6M-171.0% | -$43.4M+50.7% | -$88.0M |
| Net loss attributable to common shares —diluted | -$143.1M-7.9% | -$132.6M-12.7% | -$117.6M-171.0% | -$43.4M+50.7% | -$88.0M |
| Net loss per share attributable to common shares - basic | -$730.00+3.9% | -$760.00+6.2% | -$810.00-118.9% | -$370.00+70.6% | -$1260.00 |
| Net loss per share attributable to common shares - diluted | -$730.00+3.9% | -$760.00+6.2% | -$810.00-118.9% | -$370.00+70.6% | -$1260.00 |
| Weighted average common shares outstanding - basic | 197.25B+12.7% | 175.03B+20.6% | 145.19B+22.4% | 118.66B+69.5% | 70.01B |
| Weighted average common shares outstanding - diluted | 197.25B+12.7% | 175.03B+20.6% | 145.19B+22.4% | 118.66B+69.5% | 70.01B |
| Product revenue | |||||
| Contract revenue | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.